Yup heart surgery is probably completely and utterly out of reach of the majority of the population. Market size? Maybe a rough guide would be to apply the incidence/prevalence of CHD in the population that has private health insurance (going by the above link, thats about 5% of the population or 66 million have private health insurance).
Using the figures used by other posters:
Number of private health insured = 66 million
Population growth = 2% x 66 million = 1.3 million p.a.
Incidence of CHD = 1% x 1.3 million = 13,200 p.a.
Number of operations = 25% x 13,200 = 3,300 p.a.
The country in itself wont be a company maker but its another market to add to the list and for sure over time a progressively larger segment of the population in India will join the ranks of those that can afford proper healthcare.
- Forums
- ASX - By Stock
- AVR
- Ann: Regulatory approval to launch CardioCel in India
Ann: Regulatory approval to launch CardioCel in India, page-64
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 191 | $17.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.80 | 10 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 191 | 17.150 |
1 | 178 | 17.050 |
1 | 196 | 16.950 |
1 | 42 | 16.900 |
1 | 1000 | 16.850 |
Price($) | Vol. | No. |
---|---|---|
16.800 | 10 | 2 |
17.150 | 90 | 1 |
17.500 | 500 | 1 |
17.800 | 200 | 1 |
18.240 | 500 | 1 |
Last trade - 16.16pm 22/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable